MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacep.2023.08.017

Медицинская библиотека · JACC. Clinical electrophysiology · 2023

The Prevalence and Characteristics of Arrhythmic Mitral Valve Prolapse in Patients With Unexplained Cardiac Arrest.

Alqarawi Wael, Tadros Rafik, Roberts Jason D, Cheung Christopher C, Green Martin S, Burwash Ian G, Steinberg Christian, Healey Jeffrey S, Khan Habib, McIntyre Ciorsti, Cadrin-Touringy Julia, Laksman Zachary W M, Simpson Christopher S, Sanatani Shubhayan, Gardner Martin, Angaran Paul, Ilhan Erkan, Talajic Mario, Arbour Laura, Leather Richard, Seifer Colette, Joza Jacqueline, Lee Felicity, Lau Lawrence, Nair Girish, Wells George, Krahn Andrew D

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

There is growing evidence that mitral valve prolapse (MVP) is associated with otherwise unexplained cardiac arrest (UCA). However, reports are hindered by the absence of a systematic ascertainment of alternative diagnoses.

OBJECTIVES

This study reports the prevalence and characteristics of MVP in a large cohort of patients with UCA.

METHODS

Patients were enrolled following an UCA, defined as cardiac arrest with no coronary artery disease, preserved left ventricular ejection fraction, and no apparent explanation on electrocardiogram. A comprehensive evaluation was performed, and patients were diagnosed with idiopathic ventricular fibrillation (IVF) if no cause was found. Echocardiography reports were reviewed for MVP. Patients with MVP were divided into 2 groups: those with IVF (AMVP) and those with an alternative diagnosis (nonarrhythmic MVP). Patient characteristics were then compared. The long-term outcomes of AMVP were reported.

RESULTS

Among 571 with an initially UCA, 34 patients had MVP (6%). The prevalence of definite MVP was significantly higher in patients with IVF than those with an alternative diagnosis (24 of 366 [6.6%] vs 5 of 205 [2.4%]; P = 0.03). Bileaflet prolapse was significantly associated with AMVP (18 of 23 [78%] vs 1 of 8 [12.5%]; P = 0.001; OR: 25.2). The proportion of patients with AMVP who received appropriate implantable cardioverter-defibrillator therapies over a median follow-up of 42 months was 21.1% (4 of 19).

CONCLUSIONS

MVP is associated with otherwise UCA (IVF), with a prevalence of 6.6%. Bileaflet prolapse appears to be a feature of AMVP, although future studies need to ascertain its independent association. A significant proportion of patients with AMVP received appropriate implantable cardioverter-defibrillator therapies during follow-up.

Для цитирования: Alqarawi Wael, Tadros Rafik, Roberts Jason D, Cheung Christopher C, Green Martin S, Burwash Ian G, Steinberg Christian, Healey Jeffrey S, Khan Habib, McIntyre Ciorsti, Cadrin-Touringy Julia, Laksman Zachary W M, Simpson Christopher S, Sanatani Shubhayan, Gardner Martin, Angaran Paul, Ilhan Erkan, Talajic Mario, Arbour Laura, Leather Richard, Seifer Colette, Joza Jacqueline, Lee Felicity, Lau Lawrence, Nair Girish, Wells George, Krahn Andrew D. The Prevalence and Characteristics of Arrhythmic Mitral Valve Prolapse in Patients With Unexplained Cardiac Arrest.. JACC. Clinical electrophysiology. 2023. DOI: 10.1016/j.jacep.2023.08.017.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.